|
86
|
296
|
2wevA |
Truncation and optimisation of peptide inhibitors of cdk2, cyclin a through structure guided design |
|
77
|
298
|
2w1hA |
Fragment-based discovery of the pyrazol-4-yl urea (at9283), a multi- targeted kinase inhibitor with potent aurora kinase activity |
|
57
|
289
|
2w96B |
Crystal structure of cdk4 in complex with a d-type cyclin |
|
61
|
291
|
2w9zB |
Crystal structure of cdk4 in complex with a d-type cyclin |
|
84
|
298
|
2vtlA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
75
|
298
|
2vtsA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
80
|
298
|
2vtqA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
77
|
298
|
2vtjA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
82
|
298
|
2vtmA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
79
|
298
|
2vthA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
81
|
298
|
2vtpA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
78
|
298
|
2vtaA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
74
|
298
|
2w17A |
Cdk2 in complex with the imidazole pyrimidine amide, compound (s)-8b |
|
78
|
298
|
2vtiA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
78
|
298
|
2vv9A |
Cdk2 in complex with an imidazole piperazine |
|
76
|
298
|
2w06A |
Structure of cdk2 in complex with an imidazolyl pyrimidine, compound 5c |
|
79
|
298
|
2vtnA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
78
|
298
|
2vtoA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
76
|
298
|
2w05A |
Structure of cdk2 in complex with an imidazolyl pyrimidine, compound 5b |
|
79
|
298
|
2vu3A |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
82
|
298
|
2vtrA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design |
|
75
|
298
|
2vttA |
Identification of n-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1h- pyrazole-3-carboxamide (at7519), a novel cyclin dependent kinase inhibitor using fragment-based x-ray crystallography and structure based drug design. |
|
88
|
296
|
2uzdA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
82
|
296
|
2v22A |
Replace: a strategy for iterative design of cyclin binding groove inhibitors |
|
75
|
298
|
2uznA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
78
|
298
|
2v0dA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
87
|
296
|
2uzeA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
76
|
296
|
2uzoA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
84
|
296
|
2uzlA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
80
|
296
|
2uzbA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
81
|
296
|
2uueA |
Replace: a strategy for iterative design of cyclin binding groove inhibitors |
|
79
|
298
|
2r3lA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
83
|
298
|
2r3nA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
75
|
298
|
2r3jA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
86
|
298
|
2r3pA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
81
|
298
|
2r3mA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
87
|
298
|
2r3hA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
298
|
2r64A |
Crystal structure of a 3-aminoindazole compound with cdk2 |
|
84
|
298
|
2r3rA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
84
|
298
|
2r3fA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
86
|
298
|
2r3qA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
83
|
298
|
2r3oA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
298
|
2r3kA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
83
|
298
|
2r3iA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
81
|
298
|
2r3gA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
69
|
296
|
2qkrA |
Cryptosporidium parvum cyclin-dependent kinase cgd5_2510 with indirubin 3'-monoxime bound |
|
71
|
295
|
2pk9A |
Structure of the pho85-pho80 cdk-cyclin complex of the phosphate-responsive signal transduction pathway |
|
73
|
284
|
2pmiA |
Structure of the pho85-pho80 cdk-cyclin complex of the phosphate-responsive signal transduction pathway with bound atp-gamma-s |
|
74
|
289
|
2jgzA |
Crystal structure of phospho-cdk2 in complex with cyclin b |
|
77
|
298
|
2j9mA |
Crystal structure of cdk2 in complex with macrocyclic aminopyrimidine |
